Annie Borel‐Derlon

Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A

Jenny Goudemand, Chantal Rothschild, Virginie Demiguel et al. · Blood · 2005 · 293 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies

J. Lepercq, Jacqueline Conard, Annie Borel‐Derlon et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2001 · 274 citations

Medicine, Maternal Health, Obstetrics +15

VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors

Suryasarathi Dasgupta, Yohann Repessé, Jagadeesh Bayry et al. · Blood · 2006 · 190 citations

Life Sciences, Cell Biology, Immunology +9

Treatment of severe von Willebrand disease with a high‐purity von Willebrand factor concentrate (Wilfactin®): a prospective study of 50 patients

Annie Borel‐Derlon, Augusto B. Federici, V. Roussel‐Robert et al. · Journal of Thrombosis and Haemostasis · 2007 · 123 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies

J. Lepercq, Jacqueline Conard, Annie Borel‐Derlon et al. · British Journal of Obstetrics and Gynaecology · 2001 · 92 citations

Medicine, Maternal Health, Obstetrics +15